Meeting of the CDER Antiviral Drugs Advisory Committee
CONSULTANTS AND GUESTS
Special Government Employee (SGE) Consultants (Voting)
Robert Grant M.D., M.P.H., M.S.
Associate Professor of Medicine
Gladstone Institute of Virology and Immunology
San Francisco, CA 94158
Director, Forum for Collaborative HIV Research
Department of Prevention and Community Health
Stephen Hall, Ph.D.
Professor of Medicine
Associate Clinical Professor
Pediatric Pharmacology Research Unit
9500 Gilman Drive
La Jolla, CA 92093-0979
Gene Morse, Pharm.D.
Department of Pharmacy Practice
317 Hochstetter Hall
Government Employee Consultant (Voting)
HIV Drug Resistance Program, NCI, NIH
Bldg. 10, Room 8C301
Special Government Employee (SGE) Consultant (Non-voting)
Princy Kumar, Ph.D
Chief, Associate Professor of Medicine
Division of Infectious Diseases
SGE Patient Representative (Non-voting)
Lynda Dee, J.D., AIDS Action Baltimore,
FDA Participants at the Table (Non-voting)
Mark J. Goldberger, M.D., M.P.H.
Director, Office of Drug Evaluation IV, CDER
Debra B. Birnkrant, M.D.
Director, Division of Antiviral Drug Products, CDER
Rosemary Johann-Liang, M.D.
Medical Team Leader, Division of Antiviral Drug Products, CDER
Andrea James, M.D.
Medical Officer, Division of Antiviral Drug Products, CDER